“…Infections with these pathogens are especially dangerous in immunocompromised patients, e.g., in solid organ transplant recipients on chronic immunosuppressive therapy [ 7 ] or in hemodialysis patients [ 8 ]. Enterobacter cloacae , the main representative of Enterobacter spp., colonizes the mucosa of the human intestine in a physiological state; however, it is also described as the source of many different disorders, including bacteremia [ 9 , 10 ], urinary tract infections (UTIs) [ 11 , 12 ], wound infections [ 13 , 14 , 15 ], osteoarticular infections [ 16 , 17 , 18 ], and pneumonia/lower respiratory tract infections [ 19 , 20 , 21 ]. These bacteria also commonly colonize in various hospital wards, including neonatal intensive care units, which may result in the development of life-threatening infections such as meningitidis [ 22 ].…”